Words for clinical notes
Search 5,131 terms by clinical wording, everyday description, or note example.
| Word | Plain-English search cue | Original note example | SOAP section | Writing task |
|---|---|---|---|---|
amplification inhibition | sample contains substances that interfere with the amplification reaction | Amplification inhibition was reported when the internal control failed. | Objective | Molecular testing, serology and culture findings |
internal amplification control | control used to assess whether the amplification reaction functioned as expected | Internal amplification control failed in the first sample and passed on the repeat. | Objective | Molecular testing, serology and culture findings |
target detected | assay identified the specific sequence or analyte being tested for | The report states "target detected" for one target on the respiratory panel. | Objective | Molecular testing, serology and culture findings |
target not detected | specified assay target was not identified in the submitted sample | The result states "target not detected" for the named target in this specimen. | Objective | Molecular testing, serology and culture findings |
invalid molecular result | assay could not generate an interpretable answer for the submitted sample | The invalid molecular result was reported with the laboratory's reason. | Objective | Molecular testing, serology and culture findings |
equivocal serology | antibody or antigen result falls into the assay's indeterminate zone | Equivocal serology was recorded with the assay-specific cutoff information. | Objective | Molecular testing, serology and culture findings |
paired sera | two serum specimens obtained at different stages of illness for comparison | Paired sera were submitted with the collection dates and symptom onset date. | Objective | Molecular testing, serology and culture findings |
acute-phase serum | blood serum collected early in the course of an illness | Acute-phase serum was labeled with the day of illness. | Objective | Molecular testing, serology and culture findings |
convalescent serum | blood serum obtained later to compare with an earlier illness sample | Convalescent serum was tested alongside the acute specimen. | Objective | Molecular testing, serology and culture findings |
antibody avidity | measure of the overall binding strength of an antibody population | Antibody avidity was reported with the assay-specific interpretation. | Objective | Molecular testing, serology and culture findings |
hepatitis B surface antigen | viral surface protein tested as a marker of current hepatitis B infection | The hepatitis B surface antigen was confirmed on repeat testing. | Objective | Molecular testing, serology and culture findings |
hepatitis B surface antibody | antibody to hepatitis B surface antigen | The hepatitis B surface antibody was reported with the core antibody and vaccination history. | Objective | Molecular testing, serology and culture findings |
total hepatitis B core antibody | test for antibodies to the core antigen that can reflect prior or current natural infection | The total hepatitis B core antibody was interpreted together with surface antigen and surface antibody. | Objective | Molecular testing, serology and culture findings |
IgM hepatitis B core antibody | core antibody isotype used in assessing recent infection or some flares | The IgM hepatitis B core antibody was reported with the hepatitis B surface antigen. | Objective | Molecular testing, serology and culture findings |
hepatitis B e antigen | viral antigen associated with active replication in many infections | The hepatitis B e antigen was recorded alongside the viral DNA result. | Objective | Molecular testing, serology and culture findings |
hepatitis B viral load | amount of hepatitis B virus DNA measured in a specified sample | Hepatitis B viral load was reported with units and the lower reporting limit. | Objective | Molecular testing, serology and culture findings |
hepatitis C antibody | serologic marker of exposure to hepatitis C virus | The hepatitis C antibody was reactive and recorded separately from the RNA result. | Objective | Molecular testing, serology and culture findings |
hepatitis C RNA | viral RNA measured to assess current hepatitis C viremia | Hepatitis C RNA was reported with its detection qualifier. | Objective | Molecular testing, serology and culture findings |
HIV antigen-antibody screen | screening test that detects HIV antibodies and p24 antigen | HIV antigen-antibody screen was recorded with the subsequent differentiation result. | Objective | Molecular testing, serology and culture findings |
HIV differentiation assay | supplemental test used to distinguish HIV-1 from HIV-2 antibodies | The HIV differentiation assay was reviewed as part of the reported testing sequence. | Objective | Molecular testing, serology and culture findings |
HIV RNA viral load | measured amount of HIV RNA in the specimen | HIV RNA viral load was recorded in copies per milliliter with the collection date. | Objective | Molecular testing, serology and culture findings |
CD4 percentage | proportion of lymphocytes identified as CD4-positive T cells | The CD4 percentage was interpreted alongside the absolute CD4 count. | Objective | Molecular testing, serology and culture findings |
absolute CD4 count | number of CD4-positive T cells in a defined volume of blood | The absolute CD4 count was recorded separately from the CD4 percentage. | Objective | Molecular testing, serology and culture findings |
cryptococcal antigen | test for a capsular antigen from Cryptococcus | The cryptococcal antigen was reported with the specimen type and titer, when provided. | Objective | Molecular testing, serology and culture findings |
galactomannan index | assay index measuring a fungal cell-wall antigen in the submitted specimen | The galactomannan index was documented with the assay and specimen source. | Objective | Molecular testing, serology and culture findings |